A national trial on the treatment of invasive bladder cancer.
A new anti-cancer agent, misonidazole, is now available for investigational purposes. It is a radiation sensitiser, and a national trial is described for its use in the curative treatment of carcinoma of the bladder. The co-operation of doctors is sought in referring patients for this study.
D002277:Carcinoma / Q000188:drug therapy* / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D006801:Humans; D008920:Misonidazole / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D009367:Neoplasm Staging; D009520:New Zealand; D009593:Nitroimidazoles / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D014839:Vomiting / Q000139:chemically induced
D009593:Nitroimidazoles; D008920:Misonidazole